DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.69 +0.02 (+0.23%)
At close: Oct 21, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Revenue (2018)

Updated

DiaMedica Therapeutics' Revenue came in at $500,000 for FY2018.

Analysis

DiaMedica Therapeutics (DMAC) Revenue (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 DiaMedica Therapeutics 469.96 Mn 259.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 500,000.00
API Access

DiaMedica Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=DMAC&period=max&api_key=YOUR_API_KEY